These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R. Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521 [Abstract] [Full Text] [Related]
7. Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis. Lee L, Kelly J, Nassif GJ, Atallah SB, Albert MR, Shridhar R, Monson JRT. J Gastrointest Surg; 2017 Oct; 21(10):1666-1674. PubMed ID: 28819913 [Abstract] [Full Text] [Related]
8. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Perez RO, Habr-Gama A, Lynn PB, São Julião GP, Bianchi R, Proscurshim I, Gama-Rodrigues J. Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274 [Abstract] [Full Text] [Related]
9. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis. Renz P, Wegner RE, Hasan S, Brookover R, Finley G, Monga D, Raj M, McCormick J, Kirichenko A. Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549 [Abstract] [Full Text] [Related]
10. A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit? Cutting JE, Hallam SE, Thomas MG, Messenger DE. Colorectal Dis; 2018 Oct; 20(10):854-863. PubMed ID: 29992729 [Abstract] [Full Text] [Related]
12. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. Arezzo A, Lo Secco G, Passera R, Esposito L, Guerrieri M, Ortenzi M, Bujko K, Perez RO, Habr-Gama A, Stipa F, Picchio M, Restivo A, Zorcolo L, Coco C, Rizzo G, Mistrangelo M, Morino M. Tech Coloproctol; 2019 Sep; 23(9):831-842. PubMed ID: 31388861 [Abstract] [Full Text] [Related]
13. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. Nguyen P, Wuthrick E, Chablani P, Robinson A, Simmons L, Wu C, Arnold M, Harzman AE, Husain S, Schmidt C, Abdel-Misih S, Bekaii-Saab T, Chakravarti A, Williams TM. Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992 [Abstract] [Full Text] [Related]
15. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases. Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB. Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654 [Abstract] [Full Text] [Related]
19. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review. Zinicola R, Nascimbeni R, Cirocchi R, Gagliardi G, Cracco N, Giuffrida M, Pedrazzi G, Binda GA. Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121 [Abstract] [Full Text] [Related]
20. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Caricato M, Borzomati D, Ausania F, Tonini G, Rabitti C, Valeri S, Trodella L, Ripetti V, Coppola R. Surg Endosc; 2006 Aug; 20(8):1203-7. PubMed ID: 16703429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]